date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.537693538843358.
The log-likelihood improved by 4.011.
Iteration 2 of at most 500:
Optimizing with step length 0.792158050014565.
The log-likelihood improved by 2.856.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1597.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.08804.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       18     1161     1007      796      340      367      365 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     330      224      185       86       58       32       20        6 
degree16 
       3 
1 
disease_progression 
H-positive risk:  900 881 119 860 444 114 840 451 129 62 138 62 
H-negative risk:  881 900 840 860 451 444 114 119 138 129 62 62 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 1 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
2 
disease_progression 
H-positive risk:  902 885 120 864 437 114 836 449 131 62 139 61 
H-negative risk:  885 902 836 864 449 437 114 120 139 131 61 62 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 3 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
3 
disease_progression 
H-positive risk:  903 894 126 863 431 116 833 442 129 62 140 61 
H-negative risk:  894 903 833 863 442 431 116 126 140 129 61 62 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 6 2 

clinical_engagement 
diagnosis 
demography 
69 new agents 
4 
disease_progression 
H-positive risk:  910 901 126 863 425 116 835 437 128 62 137 60 
H-negative risk:  901 910 835 863 437 425 116 126 137 128 60 62 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 8 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
5 
disease_progression 
H-positive risk:  910 914 125 857 423 115 832 435 130 61 139 59 
H-negative risk:  914 910 832 857 435 423 115 125 139 130 59 61 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 10 2 

clinical_engagement 
diagnosis 
demography 
70 new agents 
6 
disease_progression 
H-positive risk:  910 918 126 859 425 115 834 424 132 61 138 58 
H-negative risk:  918 910 834 859 424 425 115 126 138 132 58 61 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 13 3 

clinical_engagement 
diagnosis 
demography 
56 new agents 
7 
disease_progression 
H-positive risk:  919 924 126 858 425 116 832 420 131 58 138 53 
H-negative risk:  924 919 832 858 420 425 116 126 138 131 53 58 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 16 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
8 
disease_progression 
H-positive risk:  928 931 127 854 418 115 827 420 132 59 136 53 
H-negative risk:  931 928 827 854 420 418 115 127 136 132 53 59 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 14 3 

clinical_engagement 
diagnosis 
demography 
62 new agents 
9 
disease_progression 
H-positive risk:  928 934 129 855 413 116 831 419 130 61 134 50 
H-negative risk:  934 928 831 855 419 413 116 129 134 130 50 61 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 18 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
10 
disease_progression 
H-positive risk:  935 937 129 854 408 116 836 417 128 60 131 49 
H-negative risk:  937 935 836 854 417 408 116 129 131 128 49 60 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 18 3 

clinical_engagement 
diagnosis 
demography 
68 new agents 
11 
disease_progression 
H-positive risk:  940 943 129 857 396 117 837 410 129 62 131 49 
H-negative risk:  943 940 837 857 410 396 117 129 131 129 49 62 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 18 3 

clinical_engagement 
diagnosis 
demography 
67 new agents 
12 
disease_progression 
H-positive risk:  940 945 127 863 393 117 837 407 128 63 134 46 
H-negative risk:  945 940 837 863 407 393 117 127 134 128 46 63 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 19 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
13 
disease_progression 
H-positive risk:  884 864 119 950 391 108 905 401 131 62 139 46 
H-negative risk:  864 884 905 950 401 391 108 119 139 131 46 62 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
215 new agents 
14 
disease_progression 
H-positive risk:  918 905 121 895 412 112 862 403 124 64 132 52 
H-negative risk:  905 918 862 895 403 412 112 121 132 124 52 64 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 20 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
15 
disease_progression 
H-positive risk:  921 907 123 898 406 113 866 398 121 63 131 53 
H-negative risk:  907 921 866 898 398 406 113 123 131 121 53 63 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 19 10 

clinical_engagement 
diagnosis 
demography 
53 new agents 
16 
disease_progression 
H-positive risk:  922 915 125 901 402 113 868 386 120 64 132 52 
H-negative risk:  915 922 868 901 386 402 113 125 132 120 52 64 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 21 10 

clinical_engagement 
diagnosis 
demography 
53 new agents 
17 
disease_progression 
H-positive risk:  917 918 127 898 403 112 872 383 121 66 131 52 
H-negative risk:  918 917 872 898 383 403 112 127 131 121 52 66 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 23 10 

clinical_engagement 
diagnosis 
demography 
62 new agents 
18 
disease_progression 
H-positive risk:  914 926 126 901 398 113 866 386 121 64 133 52 
H-negative risk:  926 914 866 901 386 398 113 126 133 121 52 64 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 23 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
19 
disease_progression 
H-positive risk:  917 924 125 902 393 116 865 387 122 65 133 51 
H-negative risk:  924 917 865 902 387 393 116 125 133 122 51 65 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 24 13 

clinical_engagement 
diagnosis 
demography 
66 new agents 
20 
disease_progression 
H-positive risk:  919 931 127 908 392 115 852 384 123 64 133 52 
H-negative risk:  931 919 852 908 384 392 115 127 133 123 52 64 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 27 13 

clinical_engagement 
diagnosis 
demography 
64 new agents 
21 
disease_progression 
H-positive risk:  923 938 128 909 389 114 847 381 123 63 133 52 
H-negative risk:  938 923 847 909 381 389 114 128 133 123 52 63 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 29 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
22 
disease_progression 
H-positive risk:  927 939 132 904 385 113 843 381 124 64 135 53 
H-negative risk:  939 927 843 904 381 385 113 132 135 124 53 64 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 30 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
23 
disease_progression 
H-positive risk:  929 944 132 896 382 115 851 376 125 63 134 53 
H-negative risk:  944 929 851 896 376 382 115 132 134 125 53 63 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 32 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
24 
disease_progression 
H-positive risk:  936 943 132 895 375 113 855 377 125 64 134 51 
H-negative risk:  943 936 855 895 377 375 113 132 134 125 51 64 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 37 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
25 
disease_progression 
H-positive risk:  874 895 122 950 369 105 914 379 134 63 142 53 
H-negative risk:  895 874 914 950 379 369 105 122 142 134 53 63 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 38 15 

clinical_engagement 
diagnosis 
demography 
179 new agents 
26 
disease_progression 
H-positive risk:  897 913 130 928 379 107 868 399 130 63 129 57 
H-negative risk:  913 897 868 928 399 379 107 130 129 130 57 63 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 37 16 

clinical_engagement 
diagnosis 
demography 
54 new agents 
27 
disease_progression 
H-positive risk:  904 921 129 915 383 107 864 400 134 60 128 55 
H-negative risk:  921 904 864 915 400 383 107 129 128 134 55 60 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 40 16 

clinical_engagement 
diagnosis 
demography 
52 new agents 
28 
disease_progression 
H-positive risk:  903 919 133 917 375 107 866 404 133 59 128 56 
H-negative risk:  919 903 866 917 404 375 107 133 128 133 56 59 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 41 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
29 
disease_progression 
H-positive risk:  907 919 134 913 377 108 863 402 134 58 128 57 
H-negative risk:  919 907 863 913 402 377 108 134 128 134 57 58 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 43 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
30 
disease_progression 
H-positive risk:  913 914 132 915 375 110 868 397 137 57 127 55 
H-negative risk:  914 913 868 915 397 375 110 132 127 137 55 57 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 43 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
31 
disease_progression 
H-positive risk:  921 913 128 916 376 111 872 390 135 55 128 55 
H-negative risk:  913 921 872 916 390 376 111 128 128 135 55 55 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 45 17 

clinical_engagement 
diagnosis 
demography 
53 new agents 
32 
disease_progression 
H-positive risk:  922 921 128 906 374 111 871 387 138 56 131 55 
H-negative risk:  921 922 871 906 387 374 111 128 131 138 55 56 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 46 17 

clinical_engagement 
diagnosis 
demography 
52 new agents 
33 
disease_progression 
H-positive risk:  924 923 133 906 367 110 874 389 136 55 128 55 
H-negative risk:  923 924 874 906 389 367 110 133 128 136 55 55 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 47 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
34 
disease_progression 
H-positive risk:  926 917 133 910 368 110 872 391 138 55 124 56 
H-negative risk:  917 926 872 910 391 368 110 133 124 138 56 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 48 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
35 
disease_progression 
H-positive risk:  931 919 133 908 369 114 872 382 139 55 122 56 
H-negative risk:  919 931 872 908 382 369 114 133 122 139 56 55 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
36 
disease_progression 
H-positive risk:  933 923 130 913 364 115 871 380 137 55 124 55 
H-negative risk:  923 933 871 913 380 364 115 130 124 137 55 55 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
37 
disease_progression 
H-positive risk:  861 861 123 971 366 104 944 375 150 58 133 54 
H-negative risk:  861 861 944 971 375 366 104 123 133 150 54 58 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
152 new agents 
38 
disease_progression 
H-positive risk:  867 874 125 951 381 107 926 377 144 66 126 56 
H-negative risk:  874 867 926 951 377 381 107 125 126 144 56 66 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 59 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
39 
disease_progression 
H-positive risk:  869 878 122 941 382 106 928 376 143 69 131 55 
H-negative risk:  878 869 928 941 376 382 106 122 131 143 55 69 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 59 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
40 
disease_progression 
H-positive risk:  873 879 119 945 381 106 926 375 140 69 133 54 
H-negative risk:  879 873 926 945 375 381 106 119 133 140 54 69 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
47 new agents 
41 
disease_progression 
H-positive risk:  872 882 120 941 385 107 923 376 139 66 136 53 
H-negative risk:  882 872 923 941 376 385 107 120 136 139 53 66 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 59 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
42 
disease_progression 
H-positive risk:  875 889 120 938 382 104 922 379 136 67 135 53 
H-negative risk:  889 875 922 938 379 382 104 120 135 136 53 67 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 61 22 

clinical_engagement 
diagnosis 
demography 
57 new agents 
43 
disease_progression 
H-positive risk:  873 893 119 938 384 105 925 373 134 68 136 52 
H-negative risk:  893 873 925 938 373 384 105 119 136 134 52 68 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 63 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
44 
disease_progression 
H-positive risk:  876 893 117 936 377 105 937 368 134 68 136 53 
H-negative risk:  893 876 937 936 368 377 105 117 136 134 53 68 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
45 
disease_progression 
H-positive risk:  876 897 114 936 380 106 933 369 134 67 136 52 
H-negative risk:  897 876 933 936 369 380 106 114 136 134 52 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
46 
disease_progression 
H-positive risk:  875 907 113 933 387 106 930 368 134 68 131 48 
H-negative risk:  907 875 930 933 368 387 106 113 131 134 48 68 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
47 
disease_progression 
H-positive risk:  877 912 112 940 385 105 919 369 135 68 130 48 
H-negative risk:  912 877 919 940 369 385 105 112 130 135 48 68 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
48 
disease_progression 
H-positive risk:  882 911 112 936 384 107 916 372 136 68 128 48 
H-negative risk:  911 882 916 936 372 384 107 112 128 136 48 68 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
49 
disease_progression 
H-positive risk:  821 843 104 1002 390 102 983 365 144 63 137 46 
H-negative risk:  843 821 983 1002 365 390 102 104 137 144 46 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
129 new agents 
50 
disease_progression 
H-positive risk:  824 850 107 979 411 100 944 391 149 61 136 48 
H-negative risk:  850 824 944 979 391 411 100 107 136 149 48 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
51 
disease_progression 
H-positive risk:  826 852 105 968 422 101 945 387 147 59 140 48 
H-negative risk:  852 826 945 968 387 422 101 105 140 147 48 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
52 
disease_progression 
H-positive risk:  831 846 107 974 417 105 942 381 149 59 138 51 
H-negative risk:  846 831 942 974 381 417 105 107 138 149 51 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
53 
disease_progression 
H-positive risk:  835 850 110 973 417 109 935 377 150 58 136 50 
H-negative risk:  850 835 935 973 377 417 109 110 136 150 50 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
56 new agents 
54 
disease_progression 
H-positive risk:  840 854 110 974 411 109 934 377 149 57 135 50 
H-negative risk:  854 840 934 974 377 411 109 110 135 149 50 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
55 
disease_progression 
H-positive risk:  843 856 108 974 411 106 929 378 151 56 135 53 
H-negative risk:  856 843 929 974 378 411 106 108 135 151 53 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
56 
disease_progression 
H-positive risk:  845 851 108 973 416 107 933 374 147 58 135 53 
H-negative risk:  851 845 933 973 374 416 107 108 135 147 53 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
57 
disease_progression 
H-positive risk:  844 847 112 977 412 107 934 376 147 57 136 51 
H-negative risk:  847 844 934 977 376 412 107 112 136 147 51 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
58 
disease_progression 
H-positive risk:  849 848 110 977 408 108 938 369 147 55 139 52 
H-negative risk:  848 849 938 977 369 408 108 110 139 147 52 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
59 
disease_progression 
H-positive risk:  845 850 110 979 407 111 933 372 145 57 141 50 
H-negative risk:  850 845 933 979 372 407 111 110 141 145 50 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
58 new agents 
60 
disease_progression 
H-positive risk:  843 856 110 979 409 111 934 363 147 57 141 50 
H-negative risk:  856 843 934 979 363 409 111 110 141 147 50 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
61 
disease_progression 
H-positive risk:  787 807 104 1038 399 105 986 363 152 57 148 54 
H-negative risk:  807 787 986 1038 363 399 105 104 148 152 54 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
135 new agents 
62 
disease_progression 
H-positive risk:  792 805 110 1027 412 109 959 375 156 57 140 58 
H-negative risk:  805 792 959 1027 375 412 109 110 140 156 58 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
53 new agents 
63 
disease_progression 
H-positive risk:  795 809 110 1023 415 110 964 366 153 58 140 57 
H-negative risk:  809 795 964 1023 366 415 110 110 140 153 57 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
64 
disease_progression 
H-positive risk:  794 815 113 1015 418 111 956 372 151 60 138 57 
H-negative risk:  815 794 956 1015 372 418 111 113 138 151 57 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
56 new agents 
65 
disease_progression 
H-positive risk:  793 812 114 1018 412 110 963 370 155 58 138 57 
H-negative risk:  812 793 963 1018 370 412 110 114 138 155 57 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
66 
disease_progression 
H-positive risk:  799 811 114 1019 407 108 969 369 154 58 135 57 
H-negative risk:  811 799 969 1019 369 407 108 114 135 154 57 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
67 
disease_progression 
H-positive risk:  795 814 113 1023 406 106 983 357 156 56 135 56 
H-negative risk:  814 795 983 1023 357 406 106 113 135 156 56 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
68 
disease_progression 
H-positive risk:  800 817 117 1020 407 106 971 361 159 55 133 54 
H-negative risk:  817 800 971 1020 361 407 106 117 133 159 54 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
69 
disease_progression 
H-positive risk:  802 819 119 1016 403 107 983 351 158 53 135 54 
H-negative risk:  819 802 983 1016 351 403 107 119 135 158 54 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
48 new agents 
70 
disease_progression 
H-positive risk:  808 817 118 1017 396 108 988 347 158 53 136 54 
H-negative risk:  817 808 988 1017 347 396 108 118 136 158 54 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
71 
disease_progression 
H-positive risk:  803 823 116 1016 388 110 994 348 157 54 137 54 
H-negative risk:  823 803 994 1016 348 388 110 116 137 157 54 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
72 
disease_progression 
H-positive risk:  806 832 114 1014 382 110 994 345 160 55 136 52 
H-negative risk:  832 806 994 1014 345 382 110 114 136 160 52 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
73 
disease_progression 
H-positive risk:  765 785 116 1064 375 106 1032 346 166 55 138 52 
H-negative risk:  785 765 1032 1064 346 375 106 116 138 166 52 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
112 new agents 
74 
disease_progression 
H-positive risk:  779 790 117 1048 383 103 1006 370 168 52 136 48 
H-negative risk:  790 779 1006 1048 370 383 103 117 136 168 48 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
75 
disease_progression 
H-positive risk:  781 793 119 1035 394 102 998 371 169 52 138 48 
H-negative risk:  793 781 998 1035 371 394 102 119 138 169 48 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
76 
disease_progression 
H-positive risk:  780 789 121 1037 390 103 998 372 169 52 138 51 
H-negative risk:  789 780 998 1037 372 390 103 121 138 169 51 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
77 
disease_progression 
H-positive risk:  775 791 120 1041 384 100 999 379 168 53 140 50 
H-negative risk:  791 775 999 1041 379 384 100 120 140 168 50 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
78 
disease_progression 
H-positive risk:  779 793 120 1041 382 103 990 383 166 56 138 49 
H-negative risk:  793 779 990 1041 383 382 103 120 138 166 49 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
79 
disease_progression 
H-positive risk:  777 787 120 1053 380 102 993 380 167 54 141 46 
H-negative risk:  787 777 993 1053 380 380 102 120 141 167 46 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
80 
disease_progression 
H-positive risk:  785 787 121 1043 389 102 991 379 163 55 142 43 
H-negative risk:  787 785 991 1043 379 389 102 121 142 163 43 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
81 
disease_progression 
H-positive risk:  787 794 120 1038 385 101 995 370 166 55 147 42 
H-negative risk:  794 787 995 1038 370 385 101 120 147 166 42 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
82 
disease_progression 
H-positive risk:  790 794 121 1028 388 102 994 367 167 55 150 44 
H-negative risk:  794 790 994 1028 367 388 102 121 150 167 44 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
83 
disease_progression 
H-positive risk:  788 795 120 1034 385 101 991 368 170 54 151 43 
H-negative risk:  795 788 991 1034 368 385 101 120 151 170 43 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
84 
disease_progression 
H-positive risk:  788 791 121 1033 380 102 998 371 171 52 152 41 
H-negative risk:  791 788 998 1033 371 380 102 121 152 171 41 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
85 
disease_progression 
H-positive risk:  744 753 118 1080 379 93 1040 370 177 54 152 40 
H-negative risk:  753 744 1040 1080 370 379 93 118 152 177 40 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 96 20 

clinical_engagement 
diagnosis 
demography 
107 new agents 
86 
disease_progression 
H-positive risk:  743 748 117 1075 386 95 1028 386 173 56 149 44 
H-negative risk:  748 743 1028 1075 386 386 95 117 149 173 44 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
87 
disease_progression 
H-positive risk:  742 744 119 1069 394 94 1024 392 174 53 151 44 
H-negative risk:  744 742 1024 1069 392 394 94 119 151 174 44 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
90 new agents 
88 
disease_progression 
H-positive risk:  746 741 118 1069 388 93 1021 399 182 52 147 44 
H-negative risk:  741 746 1021 1069 399 388 93 118 147 182 44 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
89 
disease_progression 
H-positive risk:  747 745 118 1070 387 92 1020 396 182 51 146 46 
H-negative risk:  745 747 1020 1070 396 387 92 118 146 182 46 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
90 
disease_progression 
H-positive risk:  748 741 118 1077 383 94 1023 394 181 51 146 44 
H-negative risk:  741 748 1023 1077 394 383 94 118 146 181 44 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
91 
disease_progression 
H-positive risk:  745 744 118 1072 381 95 1025 395 182 55 145 43 
H-negative risk:  744 745 1025 1072 395 381 95 118 145 182 43 55 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 100 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
92 
disease_progression 
H-positive risk:  750 737 118 1081 378 95 1015 400 181 53 149 43 
H-negative risk:  737 750 1015 1081 400 378 95 118 149 181 43 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 99 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
93 
disease_progression 
H-positive risk:  748 743 119 1075 379 95 1023 392 179 54 150 43 
H-negative risk:  743 748 1023 1075 392 379 95 119 150 179 43 54 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
94 
disease_progression 
H-positive risk:  748 748 119 1076 372 98 1025 389 175 57 149 44 
H-negative risk:  748 748 1025 1076 389 372 98 119 149 175 44 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 96 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
95 
disease_progression 
H-positive risk:  750 749 121 1073 373 97 1030 388 171 57 149 42 
H-negative risk:  749 750 1030 1073 388 373 97 121 149 171 42 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
96 
disease_progression 
H-positive risk:  756 755 121 1066 365 97 1037 387 170 55 149 42 
H-negative risk:  755 756 1037 1066 387 365 97 121 149 170 42 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
97 
disease_progression 
H-positive risk:  714 715 107 1112 361 91 1081 379 181 57 161 41 
H-negative risk:  715 714 1081 1112 379 361 91 107 161 181 41 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
98 
disease_progression 
H-positive risk:  716 714 108 1106 376 91 1057 399 177 55 154 47 
H-negative risk:  714 716 1057 1106 399 376 91 108 154 177 47 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 100 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
99 
disease_progression 
H-positive risk:  719 716 110 1103 369 91 1055 403 171 60 154 49 
H-negative risk:  716 719 1055 1103 403 369 91 110 154 171 49 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 99 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
100 
disease_progression 
H-positive risk:  726 722 109 1103 364 89 1052 399 175 60 153 48 
H-negative risk:  722 726 1052 1103 399 364 89 109 153 175 48 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
101 
disease_progression 
H-positive risk:  729 722 109 1097 359 90 1054 403 173 60 154 50 
H-negative risk:  722 729 1054 1097 403 359 90 109 154 173 50 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
102 
disease_progression 
H-positive risk:  725 728 108 1101 354 92 1055 401 173 59 155 49 
H-negative risk:  728 725 1055 1101 401 354 92 108 155 173 49 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
103 
disease_progression 
H-positive risk:  732 727 107 1109 354 90 1042 408 170 56 156 49 
H-negative risk:  727 732 1042 1109 408 354 90 107 156 170 49 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
104 
disease_progression 
H-positive risk:  737 729 108 1111 351 89 1041 407 172 55 153 47 
H-negative risk:  729 737 1041 1111 407 351 89 108 153 172 47 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
105 
disease_progression 
H-positive risk:  737 734 109 1119 349 87 1039 402 170 55 151 48 
H-negative risk:  734 737 1039 1119 402 349 87 109 151 170 48 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
106 
disease_progression 
H-positive risk:  745 738 110 1117 348 86 1034 401 169 55 149 48 
H-negative risk:  738 745 1034 1117 401 348 86 110 149 169 48 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
107 
disease_progression 
H-positive risk:  743 743 113 1125 341 86 1034 393 168 56 149 49 
H-negative risk:  743 743 1034 1125 393 341 86 113 149 168 49 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
108 
disease_progression 
H-positive risk:  743 750 116 1122 340 88 1039 379 164 56 152 51 
H-negative risk:  750 743 1039 1122 379 340 88 116 152 164 51 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
109 
disease_progression 
H-positive risk:  705 716 112 1154 344 79 1091 367 169 55 156 52 
H-negative risk:  716 705 1091 1154 367 344 79 112 156 169 52 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
110 
disease_progression 
H-positive risk:  697 707 113 1138 366 80 1094 374 156 64 158 53 
H-negative risk:  707 697 1094 1138 374 366 80 113 158 156 53 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
111 
disease_progression 
H-positive risk:  706 705 115 1141 362 84 1097 366 152 64 157 51 
H-negative risk:  705 706 1097 1141 366 362 84 115 157 152 51 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
112 
disease_progression 
H-positive risk:  708 703 112 1138 358 83 1101 374 153 62 158 50 
H-negative risk:  703 708 1101 1138 374 358 83 112 158 153 50 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
113 
disease_progression 
H-positive risk:  713 702 110 1140 359 84 1099 373 151 64 157 48 
H-negative risk:  702 713 1099 1140 373 359 84 110 157 151 48 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
89 new agents 
114 
disease_progression 
H-positive risk:  706 705 115 1137 355 85 1104 372 152 62 158 49 
H-negative risk:  705 706 1104 1137 372 355 85 115 158 152 49 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
115 
disease_progression 
H-positive risk:  707 695 114 1138 362 91 1097 376 151 60 158 51 
H-negative risk:  695 707 1097 1138 376 362 91 114 158 151 51 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
116 
disease_progression 
H-positive risk:  698 698 114 1135 365 92 1106 376 147 60 157 52 
H-negative risk:  698 698 1106 1135 376 365 92 114 157 147 52 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
117 
disease_progression 
H-positive risk:  696 702 114 1129 364 93 1110 370 149 63 157 53 
H-negative risk:  702 696 1110 1129 370 364 93 114 157 149 53 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
118 
disease_progression 
H-positive risk:  701 707 113 1125 367 94 1108 362 151 62 157 53 
H-negative risk:  707 701 1108 1125 362 367 94 113 157 151 53 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
119 
disease_progression 
H-positive risk:  699 709 115 1128 361 93 1109 362 152 62 156 54 
H-negative risk:  709 699 1109 1128 362 361 93 115 156 152 54 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
120 
disease_progression 
H-positive risk:  697 707 114 1132 364 95 1102 365 150 63 158 53 
H-negative risk:  707 697 1102 1132 365 364 95 114 158 150 53 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
56 new agents 
121 
disease_progression 
H-positive risk:  646 666 109 1178 363 88 1149 367 156 64 163 51 
H-negative risk:  666 646 1149 1178 367 363 88 109 163 156 51 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
122 
disease_progression 
H-positive risk:  641 662 104 1170 366 86 1154 378 156 66 160 57 
H-negative risk:  662 641 1154 1170 378 366 86 104 160 156 57 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
123 
disease_progression 
H-positive risk:  637 667 109 1166 369 86 1159 368 157 67 159 56 
H-negative risk:  667 637 1159 1166 368 369 86 109 159 157 56 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
124 
disease_progression 
H-positive risk:  642 672 106 1166 363 84 1164 368 156 67 156 56 
H-negative risk:  672 642 1164 1166 368 363 84 106 156 156 56 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
125 
disease_progression 
H-positive risk:  651 669 106 1174 360 85 1161 366 155 67 153 53 
H-negative risk:  669 651 1161 1174 366 360 85 106 153 155 53 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
126 
disease_progression 
H-positive risk:  652 666 106 1179 360 86 1164 363 157 63 150 54 
H-negative risk:  666 652 1164 1179 363 360 86 106 150 157 54 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
127 
disease_progression 
H-positive risk:  647 660 110 1186 357 88 1162 368 155 64 148 55 
H-negative risk:  660 647 1162 1186 368 357 88 110 148 155 55 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
128 
disease_progression 
H-positive risk:  650 665 110 1174 365 88 1161 364 157 66 145 55 
H-negative risk:  665 650 1161 1174 364 365 88 110 145 157 55 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
129 
disease_progression 
H-positive risk:  653 670 109 1172 361 90 1147 375 159 66 143 55 
H-negative risk:  670 653 1147 1172 375 361 90 109 143 159 55 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
130 
disease_progression 
H-positive risk:  650 672 107 1176 363 93 1151 372 157 65 142 52 
H-negative risk:  672 650 1151 1176 372 363 93 107 142 157 52 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
131 
disease_progression 
H-positive risk:  646 675 104 1188 371 93 1142 374 158 61 139 49 
H-negative risk:  675 646 1142 1188 374 371 93 104 139 158 49 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
132 
disease_progression 
H-positive risk:  647 668 103 1193 368 96 1139 377 159 60 141 49 
H-negative risk:  668 647 1139 1193 377 368 96 103 141 159 49 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
133 
disease_progression 
H-positive risk:  641 671 102 1187 375 95 1138 386 153 59 146 47 
H-negative risk:  671 641 1138 1187 386 375 95 102 146 153 47 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
134 
disease_progression 
H-positive risk:  642 661 100 1181 383 97 1139 395 154 54 143 51 
H-negative risk:  661 642 1139 1181 395 383 97 100 143 154 51 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
135 
disease_progression 
H-positive risk:  640 660 101 1187 374 91 1143 401 156 51 145 51 
H-negative risk:  660 640 1143 1187 401 374 91 101 145 156 51 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
136 
disease_progression 
H-positive risk:  641 661 101 1190 379 89 1138 398 156 51 143 53 
H-negative risk:  661 641 1138 1190 398 379 89 101 143 156 53 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
137 
disease_progression 
H-positive risk:  641 661 101 1186 389 88 1130 401 156 50 145 52 
H-negative risk:  661 641 1130 1186 401 389 88 101 145 156 52 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
138 
disease_progression 
H-positive risk:  637 661 99 1189 387 85 1130 407 159 49 142 55 
H-negative risk:  661 637 1130 1189 407 387 85 99 142 159 55 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
139 
disease_progression 
H-positive risk:  639 673 99 1181 388 83 1128 406 162 49 142 50 
H-negative risk:  673 639 1128 1181 406 388 83 99 142 162 50 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
140 
disease_progression 
H-positive risk:  640 670 99 1186 383 83 1129 410 162 47 140 51 
H-negative risk:  670 640 1129 1186 410 383 83 99 140 162 51 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
141 
disease_progression 
H-positive risk:  639 678 97 1184 376 84 1132 408 162 48 142 50 
H-negative risk:  678 639 1132 1184 408 376 84 97 142 162 50 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
142 
disease_progression 
H-positive risk:  642 680 96 1188 371 84 1137 400 160 50 142 50 
H-negative risk:  680 642 1137 1188 400 371 84 96 142 160 50 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
143 
disease_progression 
H-positive risk:  644 679 97 1186 373 84 1140 400 158 49 140 50 
H-negative risk:  679 644 1140 1186 400 373 84 97 140 158 50 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
144 
disease_progression 
H-positive risk:  648 679 98 1188 369 80 1147 391 160 49 141 50 
H-negative risk:  679 648 1147 1188 391 369 80 98 141 160 50 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
145 
disease_progression 
H-positive risk:  644 672 102 1203 369 81 1149 386 157 50 136 51 
H-negative risk:  672 644 1149 1203 386 369 81 102 136 157 51 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
99 new agents 
146 
disease_progression 
H-positive risk:  641 669 102 1202 375 82 1151 393 153 49 134 49 
H-negative risk:  669 641 1151 1202 393 375 82 102 134 153 49 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
147 
disease_progression 
H-positive risk:  645 668 101 1202 369 84 1156 386 149 51 135 54 
H-negative risk:  668 645 1156 1202 386 369 84 101 135 149 54 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
148 
disease_progression 
H-positive risk:  648 668 102 1198 369 80 1155 387 154 51 134 54 
H-negative risk:  668 648 1155 1198 387 369 80 102 134 154 54 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
149 
disease_progression 
H-positive risk:  644 674 102 1195 372 81 1165 382 154 51 128 52 
H-negative risk:  674 644 1165 1195 382 372 81 102 128 154 52 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
150 
disease_progression 
H-positive risk:  642 672 102 1203 375 83 1156 383 153 52 125 54 
H-negative risk:  672 642 1156 1203 383 375 83 102 125 153 54 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
151 
disease_progression 
H-positive risk:  640 673 101 1214 367 82 1151 390 155 50 124 53 
H-negative risk:  673 640 1151 1214 390 367 82 101 124 155 53 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
152 
disease_progression 
H-positive risk:  641 676 100 1211 374 81 1147 390 153 51 124 52 
H-negative risk:  676 641 1147 1211 390 374 81 100 124 153 52 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
153 
disease_progression 
H-positive risk:  642 673 101 1213 371 80 1155 385 155 50 123 52 
H-negative risk:  673 642 1155 1213 385 371 80 101 123 155 52 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
154 
disease_progression 
H-positive risk:  642 666 102 1200 380 77 1167 383 158 49 124 52 
H-negative risk:  666 642 1167 1200 383 380 77 102 124 158 52 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
155 
disease_progression 
H-positive risk:  642 670 101 1189 386 77 1176 373 159 47 128 52 
H-negative risk:  670 642 1176 1189 373 386 77 101 128 159 52 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
156 
disease_progression 
H-positive risk:  642 676 100 1182 393 81 1175 369 157 46 128 51 
H-negative risk:  676 642 1175 1182 369 393 81 100 128 157 51 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
157 
disease_progression 
H-positive risk:  641 680 99 1176 388 80 1187 366 156 47 129 51 
H-negative risk:  680 641 1187 1176 366 388 80 99 129 156 51 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
158 
disease_progression 
H-positive risk:  633 685 102 1163 400 78 1181 377 155 50 127 49 
H-negative risk:  685 633 1181 1163 377 400 78 102 127 155 49 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
159 
disease_progression 
H-positive risk:  633 690 99 1145 411 80 1182 380 153 50 128 49 
H-negative risk:  690 633 1182 1145 380 411 80 99 128 153 49 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
160 
disease_progression 
H-positive risk:  631 686 101 1146 416 81 1185 377 152 49 128 48 
H-negative risk:  686 631 1185 1146 377 416 81 101 128 152 48 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
161 
disease_progression 
H-positive risk:  640 679 100 1145 418 82 1179 379 152 49 129 48 
H-negative risk:  679 640 1179 1145 379 418 82 100 129 152 48 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
162 
disease_progression 
H-positive risk:  632 678 98 1151 418 80 1184 377 155 51 127 49 
H-negative risk:  678 632 1184 1151 377 418 80 98 127 155 49 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
163 
disease_progression 
H-positive risk:  629 679 97 1138 422 80 1181 391 154 51 129 49 
H-negative risk:  679 629 1181 1138 391 422 80 97 129 154 49 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
164 
disease_progression 
H-positive risk:  627 679 98 1135 429 81 1174 392 156 53 129 47 
H-negative risk:  679 627 1174 1135 392 429 81 98 129 156 47 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
165 
disease_progression 
H-positive risk:  627 677 98 1143 419 81 1184 386 156 54 128 47 
H-negative risk:  677 627 1184 1143 386 419 81 98 128 156 47 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
166 
disease_progression 
H-positive risk:  628 675 97 1149 413 79 1185 384 158 58 128 46 
H-negative risk:  675 628 1185 1149 384 413 79 97 128 158 46 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
167 
disease_progression 
H-positive risk:  626 684 96 1147 417 80 1173 387 157 59 127 47 
H-negative risk:  684 626 1173 1147 387 417 80 96 127 157 47 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
168 
disease_progression 
H-positive risk:  629 684 94 1137 420 81 1177 386 160 61 125 46 
H-negative risk:  684 629 1177 1137 386 420 81 94 125 160 46 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
169 
disease_progression 
H-positive risk:  633 690 94 1145 412 79 1173 385 157 62 125 45 
H-negative risk:  690 633 1173 1145 385 412 79 94 125 157 45 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  634 691 94 1137 420 79 1160 396 154 61 128 46 
H-negative risk:  691 634 1160 1137 396 420 79 94 128 154 46 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
171 
disease_progression 
H-positive risk:  630 688 93 1151 404 80 1167 398 154 56 129 50 
H-negative risk:  688 630 1167 1151 398 404 80 93 129 154 50 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
172 
disease_progression 
H-positive risk:  636 686 93 1153 403 78 1171 393 156 56 127 48 
H-negative risk:  686 636 1171 1153 393 403 78 93 127 156 48 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
173 
disease_progression 
H-positive risk:  643 680 96 1155 401 81 1171 389 157 54 123 50 
H-negative risk:  680 643 1171 1155 389 401 81 96 123 157 50 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
174 
disease_progression 
H-positive risk:  636 681 98 1150 399 82 1179 390 158 52 126 49 
H-negative risk:  681 636 1179 1150 390 399 82 98 126 158 49 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
175 
disease_progression 
H-positive risk:  643 687 99 1156 391 84 1168 386 161 50 127 48 
H-negative risk:  687 643 1168 1156 386 391 84 99 127 161 48 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
176 
disease_progression 
H-positive risk:  646 684 99 1142 401 83 1171 379 165 53 130 47 
H-negative risk:  684 646 1171 1142 379 401 83 99 130 165 47 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
177 
disease_progression 
H-positive risk:  646 680 99 1148 403 81 1172 382 162 54 126 47 
H-negative risk:  680 646 1172 1148 382 403 81 99 126 162 47 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
178 
disease_progression 
H-positive risk:  642 674 98 1149 402 80 1163 400 159 57 128 48 
H-negative risk:  674 642 1163 1149 400 402 80 98 128 159 48 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
179 
disease_progression 
H-positive risk:  636 668 99 1154 399 80 1169 400 163 55 129 48 
H-negative risk:  668 636 1169 1154 400 399 80 99 129 163 48 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
180 
disease_progression 
H-positive risk:  636 675 101 1155 393 79 1164 400 165 55 130 47 
H-negative risk:  675 636 1164 1155 400 393 79 101 130 165 47 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
181 
disease_progression 
H-positive risk:  645 670 101 1152 399 82 1159 399 164 53 129 47 
H-negative risk:  670 645 1159 1152 399 399 82 101 129 164 47 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
182 
disease_progression 
H-positive risk:  641 678 99 1141 403 83 1158 404 161 54 129 49 
H-negative risk:  678 641 1158 1141 404 403 83 99 129 161 49 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
183 
disease_progression 
H-positive risk:  645 667 95 1150 404 84 1162 399 160 53 132 49 
H-negative risk:  667 645 1162 1150 399 404 84 95 132 160 49 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
184 
disease_progression 
H-positive risk:  644 672 98 1151 398 86 1161 399 157 53 133 48 
H-negative risk:  672 644 1161 1151 399 398 86 98 133 157 48 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
185 
disease_progression 
H-positive risk:  640 670 101 1155 407 87 1154 397 158 52 130 49 
H-negative risk:  670 640 1154 1155 397 407 87 101 130 158 49 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
186 
disease_progression 
H-positive risk:  649 672 101 1151 405 88 1145 394 162 55 130 48 
H-negative risk:  672 649 1145 1151 394 405 88 101 130 162 48 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
187 
disease_progression 
H-positive risk:  649 676 101 1154 405 89 1145 392 160 53 130 46 
H-negative risk:  676 649 1145 1154 392 405 89 101 130 160 46 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
188 
disease_progression 
H-positive risk:  646 675 100 1157 409 90 1140 393 162 54 129 45 
H-negative risk:  675 646 1140 1157 393 409 90 100 129 162 45 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  639 684 97 1153 410 91 1140 394 162 54 133 43 
H-negative risk:  684 639 1140 1153 394 410 91 97 133 162 43 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
190 
disease_progression 
H-positive risk:  640 688 97 1143 413 90 1138 391 164 54 139 43 
H-negative risk:  688 640 1138 1143 391 413 90 97 139 164 43 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
191 
disease_progression 
H-positive risk:  653 687 99 1144 421 89 1122 387 162 53 138 45 
H-negative risk:  687 653 1122 1144 387 421 89 99 138 162 45 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
192 
disease_progression 
H-positive risk:  656 681 101 1142 419 88 1121 390 166 54 137 45 
H-negative risk:  681 656 1121 1142 390 419 88 101 137 166 45 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
193 
disease_progression 
H-positive risk:  653 684 102 1139 416 88 1116 402 168 54 133 45 
H-negative risk:  684 653 1116 1139 402 416 88 102 133 168 45 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
194 
disease_progression 
H-positive risk:  651 681 102 1129 426 86 1116 404 170 54 134 47 
H-negative risk:  681 651 1116 1129 404 426 86 102 134 170 47 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
195 
disease_progression 
H-positive risk:  649 682 102 1125 423 86 1116 411 170 55 133 48 
H-negative risk:  682 649 1116 1125 411 423 86 102 133 170 48 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
196 
disease_progression 
H-positive risk:  649 687 99 1128 423 87 1107 417 170 56 130 47 
H-negative risk:  687 649 1107 1128 417 423 87 99 130 170 47 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
197 
disease_progression 
H-positive risk:  650 683 100 1130 423 86 1099 425 172 56 131 45 
H-negative risk:  683 650 1099 1130 425 423 86 100 131 172 45 56 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
198 
disease_progression 
H-positive risk:  648 690 102 1130 423 87 1094 421 172 60 131 42 
H-negative risk:  690 648 1094 1130 421 423 87 102 131 172 42 60 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
199 
disease_progression 
H-positive risk:  648 685 99 1138 428 86 1092 421 167 61 131 44 
H-negative risk:  685 648 1092 1138 421 428 86 99 131 167 44 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
200 
disease_progression 
H-positive risk:  649 689 99 1130 427 89 1091 422 168 63 128 45 
H-negative risk:  689 649 1091 1130 422 427 89 99 128 168 45 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
201 
disease_progression 
H-positive risk:  659 690 100 1120 429 89 1092 421 168 62 128 42 
H-negative risk:  690 659 1092 1120 421 429 89 100 128 168 42 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
202 
disease_progression 
H-positive risk:  658 686 101 1116 432 91 1089 422 169 61 131 44 
H-negative risk:  686 658 1089 1116 422 432 91 101 131 169 44 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
203 
disease_progression 
H-positive risk:  663 683 101 1114 430 93 1091 416 171 63 132 43 
H-negative risk:  683 663 1091 1114 416 430 93 101 132 171 43 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
204 
disease_progression 
H-positive risk:  668 678 102 1111 431 96 1084 419 172 63 134 42 
H-negative risk:  678 668 1084 1111 419 431 96 102 134 172 42 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
205 
disease_progression 
H-positive risk:  673 681 104 1109 433 95 1081 413 170 65 134 42 
H-negative risk:  681 673 1081 1109 413 433 95 104 134 170 42 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
206 
disease_progression 
H-positive risk:  667 686 102 1097 448 96 1081 417 160 70 132 44 
H-negative risk:  686 667 1081 1097 417 448 96 102 132 160 44 70 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
207 
disease_progression 
H-positive risk:  672 689 102 1090 457 95 1076 414 160 70 132 43 
H-negative risk:  689 672 1076 1090 414 457 95 102 132 160 43 70 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
208 
disease_progression 
H-positive risk:  670 690 102 1091 447 96 1085 410 163 70 132 44 
H-negative risk:  690 670 1085 1091 410 447 96 102 132 163 44 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
209 
disease_progression 
H-positive risk:  669 696 103 1089 444 95 1084 408 162 70 134 46 
H-negative risk:  696 669 1084 1089 408 444 95 103 134 162 46 70 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
210 
disease_progression 
H-positive risk:  669 689 105 1102 441 94 1073 417 164 66 132 48 
H-negative risk:  689 669 1073 1102 417 441 94 105 132 164 48 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
211 
disease_progression 
H-positive risk:  665 686 103 1108 440 92 1081 415 167 62 134 47 
H-negative risk:  686 665 1081 1108 415 440 92 103 134 167 47 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
212 
disease_progression 
H-positive risk:  671 682 100 1110 432 90 1081 424 171 57 135 47 
H-negative risk:  682 671 1081 1110 424 432 90 100 135 171 47 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
213 
disease_progression 
H-positive risk:  669 684 97 1109 429 86 1079 432 171 56 141 47 
H-negative risk:  684 669 1079 1109 432 429 86 97 141 171 47 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
214 
disease_progression 
H-positive risk:  672 690 99 1103 422 87 1084 428 172 56 140 47 
H-negative risk:  690 672 1084 1103 428 422 87 99 140 172 47 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
215 
disease_progression 
H-positive risk:  680 686 96 1098 426 85 1083 430 175 56 140 45 
H-negative risk:  686 680 1083 1098 430 426 85 96 140 175 45 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
216 
disease_progression 
H-positive risk:  689 681 94 1094 424 85 1083 433 175 55 144 43 
H-negative risk:  681 689 1083 1094 433 424 85 94 144 175 43 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
217 
disease_progression 
H-positive risk:  690 680 92 1086 427 85 1079 445 173 54 147 42 
H-negative risk:  680 690 1079 1086 445 427 85 92 147 173 42 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
218 
disease_progression 
H-positive risk:  694 677 95 1095 414 87 1074 447 173 54 147 43 
H-negative risk:  677 694 1074 1095 447 414 87 95 147 173 43 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
98 new agents 
219 
disease_progression 
H-positive risk:  696 669 97 1098 407 91 1074 450 175 56 143 44 
H-negative risk:  669 696 1074 1098 450 407 91 97 143 175 44 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
220 
disease_progression 
H-positive risk:  692 665 97 1099 415 91 1074 450 179 55 141 42 
H-negative risk:  665 692 1074 1099 450 415 91 97 141 179 42 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
221 
disease_progression 
H-positive risk:  696 658 97 1097 419 94 1068 454 178 55 142 42 
H-negative risk:  658 696 1068 1097 454 419 94 97 142 178 42 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
222 
disease_progression 
H-positive risk:  696 662 96 1100 424 94 1069 450 177 55 135 42 
H-negative risk:  662 696 1069 1100 450 424 94 96 135 177 42 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
223 
disease_progression 
H-positive risk:  693 655 96 1113 423 93 1063 458 174 56 132 44 
H-negative risk:  655 693 1063 1113 458 423 93 96 132 174 44 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
224 
disease_progression 
H-positive risk:  686 658 95 1114 427 93 1066 456 175 52 131 47 
H-negative risk:  658 686 1066 1114 456 427 93 95 131 175 47 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
225 
disease_progression 
H-positive risk:  681 653 98 1120 423 93 1068 460 172 53 132 47 
H-negative risk:  653 681 1068 1120 460 423 93 98 132 172 47 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
226 
disease_progression 
H-positive risk:  683 653 98 1120 423 95 1067 458 175 51 131 46 
H-negative risk:  653 683 1067 1120 458 423 95 98 131 175 46 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
227 
disease_progression 
H-positive risk:  681 657 99 1131 426 94 1058 452 173 54 129 46 
H-negative risk:  657 681 1058 1131 452 426 94 99 129 173 46 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
228 
disease_progression 
H-positive risk:  690 655 101 1133 423 91 1057 443 175 56 130 46 
H-negative risk:  655 690 1057 1133 443 423 91 101 130 175 46 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
229 
disease_progression 
H-positive risk:  683 649 104 1126 430 93 1055 449 173 60 132 46 
H-negative risk:  649 683 1055 1126 449 430 93 104 132 173 46 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
230 
disease_progression 
H-positive risk:  680 646 103 1123 434 94 1063 445 172 61 131 48 
H-negative risk:  646 680 1063 1123 445 434 94 103 131 172 48 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
231 
disease_progression 
H-positive risk:  686 640 99 1121 435 94 1061 455 175 60 127 47 
H-negative risk:  640 686 1061 1121 455 435 94 99 127 175 47 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
232 
disease_progression 
H-positive risk:  693 635 98 1127 434 96 1057 455 172 59 126 48 
H-negative risk:  635 693 1057 1127 455 434 96 98 126 172 48 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
233 
disease_progression 
H-positive risk:  701 641 94 1120 428 97 1059 451 174 59 128 48 
H-negative risk:  641 701 1059 1120 451 428 97 94 128 174 48 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
234 
disease_progression 
H-positive risk:  713 633 92 1127 420 97 1057 451 175 57 129 49 
H-negative risk:  633 713 1057 1127 451 420 97 92 129 175 49 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
235 
disease_progression 
H-positive risk:  705 634 93 1114 435 100 1062 449 170 59 128 51 
H-negative risk:  634 705 1062 1114 449 435 100 93 128 170 51 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
236 
disease_progression 
H-positive risk:  711 642 93 1104 441 100 1056 447 170 58 126 52 
H-negative risk:  642 711 1056 1104 447 441 100 93 126 170 52 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
237 
disease_progression 
H-positive risk:  719 640 92 1094 445 100 1049 446 173 56 130 56 
H-negative risk:  640 719 1049 1094 446 445 100 92 130 173 56 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
238 
disease_progression 
H-positive risk:  731 644 92 1090 441 100 1048 441 172 56 127 58 
H-negative risk:  644 731 1048 1090 441 441 100 92 127 172 58 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
239 
disease_progression 
H-positive risk:  727 641 96 1092 433 100 1059 446 170 55 128 53 
H-negative risk:  641 727 1059 1092 446 433 100 96 128 170 53 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
240 
disease_progression 
H-positive risk:  730 642 95 1091 432 103 1055 441 170 59 130 52 
H-negative risk:  642 730 1055 1091 441 432 103 95 130 170 52 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  729 637 96 1089 442 105 1033 455 172 58 131 53 
H-negative risk:  637 729 1033 1089 455 442 105 96 131 172 53 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
242 
disease_progression 
H-positive risk:  727 638 92 1096 445 108 1036 449 168 57 130 54 
H-negative risk:  638 727 1036 1096 449 445 108 92 130 168 54 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
243 
disease_progression 
H-positive risk:  725 627 94 1103 445 108 1036 452 169 58 128 55 
H-negative risk:  627 725 1036 1103 452 445 108 94 128 169 55 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
244 
disease_progression 
H-positive risk:  730 630 93 1097 440 107 1035 457 170 57 128 56 
H-negative risk:  630 730 1035 1097 457 440 107 93 128 170 56 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
245 
disease_progression 
H-positive risk:  723 635 91 1105 436 106 1036 458 165 59 129 57 
H-negative risk:  635 723 1036 1105 458 436 106 91 129 165 57 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
246 
disease_progression 
H-positive risk:  721 631 94 1110 435 104 1037 466 163 56 128 55 
H-negative risk:  631 721 1037 1110 466 435 104 94 128 163 55 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  731 627 89 1097 439 106 1044 467 163 55 130 52 
H-negative risk:  627 731 1044 1097 467 439 106 89 130 163 52 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
248 
disease_progression 
H-positive risk:  734 623 91 1098 445 105 1037 467 160 58 130 52 
H-negative risk:  623 734 1037 1098 467 445 105 91 130 160 52 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
249 
disease_progression 
H-positive risk:  728 622 92 1103 437 108 1052 461 156 62 128 51 
H-negative risk:  622 728 1052 1103 461 437 108 92 128 156 51 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
250 
disease_progression 
H-positive risk:  720 621 92 1092 437 105 1072 461 160 64 127 49 
H-negative risk:  621 720 1072 1092 461 437 105 92 127 160 49 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
251 
disease_progression 
H-positive risk:  721 630 95 1093 429 107 1071 453 161 66 127 47 
H-negative risk:  630 721 1071 1093 453 429 107 95 127 161 47 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
252 
disease_progression 
H-positive risk:  728 628 93 1086 433 110 1060 454 161 67 132 48 
H-negative risk:  628 728 1060 1086 454 433 110 93 132 161 48 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
253 
disease_progression 
H-positive risk:  726 630 93 1095 431 109 1053 459 159 67 127 51 
H-negative risk:  630 726 1053 1095 459 431 109 93 127 159 51 67 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
254 
disease_progression 
H-positive risk:  738 626 95 1102 428 109 1048 455 156 66 125 52 
H-negative risk:  626 738 1048 1102 455 428 109 95 125 156 52 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
255 
disease_progression 
H-positive risk:  742 633 91 1094 438 109 1044 448 155 67 126 53 
H-negative risk:  633 742 1044 1094 448 438 109 91 126 155 53 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
256 
disease_progression 
H-positive risk:  742 632 87 1096 440 108 1042 450 157 65 127 54 
H-negative risk:  632 742 1042 1096 450 440 108 87 127 157 54 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
257 
disease_progression 
H-positive risk:  743 638 89 1095 434 103 1042 449 161 64 128 54 
H-negative risk:  638 743 1042 1095 449 434 103 89 128 161 54 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
258 
disease_progression 
H-positive risk:  744 641 90 1097 427 105 1046 445 160 62 130 53 
H-negative risk:  641 744 1046 1097 445 427 105 90 130 160 53 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
259 
disease_progression 
H-positive risk:  741 646 92 1082 431 106 1049 447 161 61 132 52 
H-negative risk:  646 741 1049 1082 447 431 106 92 132 161 52 61 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
58 new agents 
260 
disease_progression 
H-positive risk:  738 641 91 1081 436 105 1052 446 160 62 137 51 
H-negative risk:  641 738 1052 1081 446 436 105 91 137 160 51 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
261 
disease_progression 
H-positive risk:  739 643 91 1080 439 103 1058 445 158 62 133 49 
H-negative risk:  643 739 1058 1080 445 439 103 91 133 158 49 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
95 new agents 
262 
disease_progression 
H-positive risk:  741 654 92 1077 435 104 1060 435 161 60 132 49 
H-negative risk:  654 741 1060 1077 435 435 104 92 132 161 49 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
263 
disease_progression 
H-positive risk:  737 654 93 1086 430 105 1052 443 159 59 133 49 
H-negative risk:  654 737 1052 1086 443 430 105 93 133 159 49 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
264 
disease_progression 
H-positive risk:  735 654 92 1091 419 105 1045 446 164 62 137 50 
H-negative risk:  654 735 1045 1091 446 419 105 92 137 164 50 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
265 
disease_progression 
H-positive risk:  737 651 88 1099 420 103 1049 443 154 63 141 52 
H-negative risk:  651 737 1049 1099 443 420 103 88 141 154 52 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
266 
disease_progression 
H-positive risk:  733 659 87 1104 407 104 1053 440 152 64 144 53 
H-negative risk:  659 733 1053 1104 440 407 104 87 144 152 53 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
267 
disease_progression 
H-positive risk:  732 662 91 1077 424 101 1055 441 155 63 143 56 
H-negative risk:  662 732 1055 1077 441 424 101 91 143 155 56 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  726 660 96 1078 422 104 1049 451 153 64 142 55 
H-negative risk:  660 726 1049 1078 451 422 104 96 142 153 55 64 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
269 
disease_progression 
H-positive risk:  733 665 94 1075 420 104 1044 451 154 64 144 52 
H-negative risk:  665 733 1044 1075 451 420 104 94 144 154 52 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
270 
disease_progression 
H-positive risk:  737 661 95 1074 422 107 1042 447 155 62 145 53 
H-negative risk:  661 737 1042 1074 447 422 107 95 145 155 53 62 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 93 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
271 
disease_progression 
H-positive risk:  737 664 94 1082 409 111 1054 436 156 63 145 49 
H-negative risk:  664 737 1054 1082 436 409 111 94 145 156 49 63 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 93 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
272 
disease_progression 
H-positive risk:  732 657 92 1081 409 113 1054 445 156 66 144 51 
H-negative risk:  657 732 1054 1081 445 409 113 92 144 156 51 66 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 93 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
273 
disease_progression 
H-positive risk:  727 659 88 1085 408 114 1060 439 156 65 146 53 
H-negative risk:  659 727 1060 1085 439 408 114 88 146 156 53 65 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
274 
disease_progression 
H-positive risk:  726 667 89 1085 412 114 1064 434 149 65 143 52 
H-negative risk:  667 726 1064 1085 434 412 114 89 143 149 52 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
275 
disease_progression 
H-positive risk:  729 671 89 1075 415 112 1061 445 146 68 141 48 
H-negative risk:  671 729 1061 1075 445 415 112 89 141 146 48 68 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
276 
disease_progression 
H-positive risk:  719 673 88 1062 422 112 1072 448 147 70 142 45 
H-negative risk:  673 719 1072 1062 448 422 112 88 142 147 45 70 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
277 
disease_progression 
H-positive risk:  723 675 89 1064 421 114 1072 445 146 69 137 45 
H-negative risk:  675 723 1072 1064 445 421 114 89 137 146 45 69 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
278 
disease_progression 
H-positive risk:  721 676 89 1065 421 115 1070 445 145 67 142 44 
H-negative risk:  676 721 1070 1065 445 421 115 89 142 145 44 67 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
279 
disease_progression 
H-positive risk:  728 673 88 1058 428 117 1068 444 146 65 141 44 
H-negative risk:  673 728 1068 1058 444 428 117 88 141 146 44 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
280 
disease_progression 
H-positive risk:  722 675 91 1051 428 116 1068 452 145 68 139 45 
H-negative risk:  675 722 1068 1051 452 428 116 91 139 145 45 68 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
95 new agents 
281 
disease_progression 
H-positive risk:  727 675 92 1052 419 116 1063 458 144 66 143 45 
H-negative risk:  675 727 1063 1052 458 419 116 92 143 144 45 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
282 
disease_progression 
H-positive risk:  719 679 94 1047 420 118 1061 468 141 68 142 43 
H-negative risk:  679 719 1061 1047 468 420 118 94 142 141 43 68 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
283 
disease_progression 
H-positive risk:  723 674 92 1056 413 116 1052 472 145 69 145 43 
H-negative risk:  674 723 1052 1056 472 413 116 92 145 145 43 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
284 
disease_progression 
H-positive risk:  716 675 93 1054 418 115 1047 479 148 67 146 42 
H-negative risk:  675 716 1047 1054 479 418 115 93 146 148 42 67 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
285 
disease_progression 
H-positive risk:  717 680 90 1047 414 117 1053 476 149 66 150 41 
H-negative risk:  680 717 1053 1047 476 414 117 90 150 149 41 66 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
286 
disease_progression 
H-positive risk:  715 680 85 1041 420 116 1057 476 153 66 151 40 
H-negative risk:  680 715 1057 1041 476 420 116 85 151 153 40 66 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
287 
disease_progression 
H-positive risk:  710 671 81 1051 414 119 1066 473 152 67 153 43 
H-negative risk:  671 710 1066 1051 473 414 119 81 153 152 43 67 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
288 
disease_progression 
H-positive risk:  709 666 80 1054 413 120 1070 476 150 68 151 43 
H-negative risk:  666 709 1070 1054 476 413 120 80 151 150 43 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
289 
disease_progression 
H-positive risk:  710 670 82 1045 413 119 1070 475 154 66 151 45 
H-negative risk:  670 710 1070 1045 475 413 119 82 151 154 45 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
107 new agents 
290 
disease_progression 
H-positive risk:  713 675 80 1055 406 118 1064 476 157 64 151 41 
H-negative risk:  675 713 1064 1055 476 406 118 80 151 157 41 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
291 
disease_progression 
H-positive risk:  709 686 80 1053 401 117 1076 467 155 66 151 39 
H-negative risk:  686 709 1076 1053 467 401 117 80 151 155 39 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
292 
disease_progression 
H-positive risk:  711 692 81 1064 391 116 1072 462 159 66 151 35 
H-negative risk:  692 711 1072 1064 462 391 116 81 151 159 35 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
293 
disease_progression 
H-positive risk:  708 692 83 1057 399 115 1076 456 161 66 153 34 
H-negative risk:  692 708 1076 1057 456 399 115 83 153 161 34 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
294 
disease_progression 
H-positive risk:  709 693 83 1060 402 112 1081 446 161 68 150 35 
H-negative risk:  693 709 1081 1060 446 402 112 83 150 161 35 68 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
295 
disease_progression 
H-positive risk:  712 692 82 1071 395 108 1082 441 162 68 152 35 
H-negative risk:  692 712 1082 1071 441 395 108 82 152 162 35 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  707 687 82 1071 382 112 1101 438 163 70 150 37 
H-negative risk:  687 707 1101 1071 438 382 112 82 150 163 37 70 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
297 
disease_progression 
H-positive risk:  715 682 81 1080 380 109 1101 434 163 67 151 37 
H-negative risk:  682 715 1101 1080 434 380 109 81 151 163 37 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
298 
disease_progression 
H-positive risk:  711 677 78 1078 390 106 1098 443 164 65 153 37 
H-negative risk:  677 711 1098 1078 443 390 106 78 153 164 37 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
299 
disease_progression 
H-positive risk:  715 679 80 1076 384 109 1090 448 164 64 151 40 
H-negative risk:  679 715 1090 1076 448 384 109 80 151 164 40 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
300 
disease_progression 
H-positive risk:  723 674 80 1073 388 110 1093 447 161 62 149 40 
H-negative risk:  674 723 1093 1073 447 388 110 80 149 161 40 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
301 
disease_progression 
H-positive risk:  718 675 79 1081 395 110 1095 436 161 61 148 41 
H-negative risk:  675 718 1095 1081 436 395 110 79 148 161 41 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
302 
disease_progression 
H-positive risk:  713 665 75 1082 404 108 1102 434 167 61 149 40 
H-negative risk:  665 713 1102 1082 434 404 108 75 149 167 40 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
303 
disease_progression 
H-positive risk:  715 671 75 1080 404 103 1102 424 171 63 151 41 
H-negative risk:  671 715 1102 1080 424 404 103 75 151 171 41 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
304 
disease_progression 
H-positive risk:  716 674 74 1069 405 103 1111 420 172 63 149 44 
H-negative risk:  674 716 1111 1069 420 405 103 74 149 172 44 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
305 
disease_progression 
H-positive risk:  711 674 72 1076 408 103 1108 415 176 60 152 45 
H-negative risk:  674 711 1108 1076 415 408 103 72 152 176 45 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
306 
disease_progression 
H-positive risk:  707 684 70 1070 414 101 1105 413 174 61 154 47 
H-negative risk:  684 707 1105 1070 413 414 101 70 154 174 47 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
307 
disease_progression 
H-positive risk:  702 687 75 1073 415 99 1103 413 170 60 155 48 
H-negative risk:  687 702 1103 1073 413 415 99 75 155 170 48 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
308 
disease_progression 
H-positive risk:  705 687 77 1067 418 97 1107 413 170 59 150 50 
H-negative risk:  687 705 1107 1067 413 418 97 77 150 170 50 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
309 
disease_progression 
H-positive risk:  709 684 77 1069 419 96 1095 418 173 60 148 52 
H-negative risk:  684 709 1095 1069 418 419 96 77 148 173 52 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
310 
disease_progression 
H-positive risk:  705 689 80 1078 411 97 1089 422 174 58 144 53 
H-negative risk:  689 705 1089 1078 422 411 97 80 144 174 53 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
311 
disease_progression 
H-positive risk:  702 694 83 1077 416 95 1091 413 172 59 143 55 
H-negative risk:  694 702 1091 1077 413 416 95 83 143 172 55 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
312 
disease_progression 
H-positive risk:  701 704 84 1070 411 100 1099 406 171 58 141 55 
H-negative risk:  704 701 1099 1070 406 411 100 84 141 171 55 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
313 
disease_progression 
H-positive risk:  708 709 83 1071 411 102 1092 401 170 57 142 54 
H-negative risk:  709 708 1092 1071 401 411 102 83 142 170 54 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
314 
disease_progression 
H-positive risk:  708 714 86 1073 407 103 1090 397 171 59 140 52 
H-negative risk:  714 708 1090 1073 397 407 103 86 140 171 52 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
315 
disease_progression 
H-positive risk:  702 721 86 1067 401 105 1103 397 164 64 138 52 
H-negative risk:  721 702 1103 1067 397 401 105 86 138 164 52 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
316 
disease_progression 
H-positive risk:  700 721 89 1066 399 105 1101 402 165 63 138 51 
H-negative risk:  721 700 1101 1066 402 399 105 89 138 165 51 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
317 
disease_progression 
H-positive risk:  699 728 88 1065 405 108 1102 390 166 63 136 50 
H-negative risk:  728 699 1102 1065 390 405 108 88 136 166 50 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
318 
disease_progression 
H-positive risk:  697 720 84 1075 406 105 1105 387 166 65 136 54 
H-negative risk:  720 697 1105 1075 387 406 105 84 136 166 54 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
319 
disease_progression 
H-positive risk:  685 719 83 1083 402 104 1107 392 169 64 137 55 
H-negative risk:  719 685 1107 1083 392 402 104 83 137 169 55 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
320 
disease_progression 
H-positive risk:  688 720 85 1072 414 103 1101 390 169 65 136 57 
H-negative risk:  720 688 1101 1072 390 414 103 85 136 169 57 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
321 
disease_progression 
H-positive risk:  690 713 83 1077 408 102 1103 401 168 64 136 55 
H-negative risk:  713 690 1103 1077 401 408 102 83 136 168 55 64 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
322 
disease_progression 
H-positive risk:  694 712 84 1086 400 101 1110 400 163 61 135 54 
H-negative risk:  712 694 1110 1086 400 400 101 84 135 163 54 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
323 
disease_progression 
H-positive risk:  691 714 84 1078 404 101 1112 400 166 57 138 55 
H-negative risk:  714 691 1112 1078 400 404 101 84 138 166 55 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
324 
disease_progression 
H-positive risk:  694 712 81 1078 408 102 1116 397 164 58 136 54 
H-negative risk:  712 694 1116 1078 397 408 102 81 136 164 54 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
325 
disease_progression 
H-positive risk:  688 708 81 1083 409 99 1115 403 165 58 137 54 
H-negative risk:  708 688 1115 1083 403 409 99 81 137 165 54 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
326 
disease_progression 
H-positive risk:  685 703 81 1087 404 99 1119 409 163 59 139 52 
H-negative risk:  703 685 1119 1087 409 404 99 81 139 163 52 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
327 
disease_progression 
H-positive risk:  693 702 78 1090 407 98 1105 405 166 58 142 56 
H-negative risk:  702 693 1105 1090 405 407 98 78 142 166 56 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
328 
disease_progression 
H-positive risk:  696 706 76 1091 405 98 1097 413 160 58 145 55 
H-negative risk:  706 696 1097 1091 413 405 98 76 145 160 55 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
329 
disease_progression 
H-positive risk:  687 699 76 1100 402 96 1107 413 162 62 141 55 
H-negative risk:  699 687 1107 1100 413 402 96 76 141 162 55 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
95 new agents 
330 
disease_progression 
H-positive risk:  693 699 80 1100 398 95 1102 419 164 60 139 51 
H-negative risk:  699 693 1102 1100 419 398 95 80 139 164 51 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
331 
disease_progression 
H-positive risk:  694 697 81 1092 407 95 1104 421 165 56 138 50 
H-negative risk:  697 694 1104 1092 421 407 95 81 138 165 50 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
332 
disease_progression 
H-positive risk:  697 699 82 1099 407 91 1100 416 166 57 138 48 
H-negative risk:  699 697 1100 1099 416 407 91 82 138 166 48 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
333 
disease_progression 
H-positive risk:  696 703 85 1091 404 91 1111 409 162 61 138 49 
H-negative risk:  703 696 1111 1091 409 404 91 85 138 162 49 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
334 
disease_progression 
H-positive risk:  687 702 82 1102 392 91 1121 409 163 62 140 49 
H-negative risk:  702 687 1121 1102 409 392 91 82 140 163 49 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
335 
disease_progression 
H-positive risk:  682 701 82 1097 398 92 1128 412 163 59 136 50 
H-negative risk:  701 682 1128 1097 412 398 92 82 136 163 50 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
336 
disease_progression 
H-positive risk:  680 703 82 1098 400 89 1123 417 161 63 137 47 
H-negative risk:  703 680 1123 1098 417 400 89 82 137 161 47 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  681 700 81 1096 410 89 1122 418 160 63 132 48 
H-negative risk:  700 681 1122 1096 418 410 89 81 132 160 48 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
338 
disease_progression 
H-positive risk:  681 703 83 1099 400 87 1122 422 162 61 129 51 
H-negative risk:  703 681 1122 1099 422 400 87 83 129 162 51 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
339 
disease_progression 
H-positive risk:  683 700 83 1092 402 88 1120 433 159 59 128 53 
H-negative risk:  700 683 1120 1092 433 402 88 83 128 159 53 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
340 
disease_progression 
H-positive risk:  692 706 85 1088 403 89 1107 438 158 59 126 49 
H-negative risk:  706 692 1107 1088 438 403 89 85 126 158 49 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
341 
disease_progression 
H-positive risk:  694 710 83 1087 405 83 1104 434 163 60 128 49 
H-negative risk:  710 694 1104 1087 434 405 83 83 128 163 49 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
342 
disease_progression 
H-positive risk:  698 712 88 1081 402 85 1106 430 161 62 126 49 
H-negative risk:  712 698 1106 1081 430 402 85 88 126 161 49 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
343 
disease_progression 
H-positive risk:  694 710 90 1083 407 86 1097 437 158 61 129 48 
H-negative risk:  710 694 1097 1083 437 407 86 90 129 158 48 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
344 
disease_progression 
H-positive risk:  690 711 88 1079 409 86 1112 428 157 62 130 48 
H-negative risk:  711 690 1112 1079 428 409 86 88 130 157 48 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
345 
disease_progression 
H-positive risk:  694 713 88 1083 408 85 1108 422 156 64 130 49 
H-negative risk:  713 694 1108 1083 422 408 85 88 130 156 49 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
346 
disease_progression 
H-positive risk:  692 710 89 1086 406 87 1102 425 159 66 129 49 
H-negative risk:  710 692 1102 1086 425 406 87 89 129 159 49 66 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
347 
disease_progression 
H-positive risk:  690 708 88 1086 413 86 1087 440 153 67 135 47 
H-negative risk:  708 690 1087 1086 440 413 86 88 135 153 47 67 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
348 
disease_progression 
H-positive risk:  696 718 88 1090 402 87 1083 435 156 69 131 45 
H-negative risk:  718 696 1083 1090 435 402 87 88 131 156 45 69 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
96 new agents 
349 
disease_progression 
H-positive risk:  699 722 89 1094 396 87 1072 438 156 72 129 46 
H-negative risk:  722 699 1072 1094 438 396 87 89 129 156 46 72 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
350 
disease_progression 
H-positive risk:  695 720 89 1098 398 86 1074 439 159 68 127 47 
H-negative risk:  720 695 1074 1098 439 398 86 89 127 159 47 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
351 
disease_progression 
H-positive risk:  688 721 85 1095 396 85 1083 445 158 69 128 47 
H-negative risk:  721 688 1083 1095 445 396 85 85 128 158 47 69 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
352 
disease_progression 
H-positive risk:  681 722 82 1097 396 85 1089 442 162 68 131 45 
H-negative risk:  722 681 1089 1097 442 396 85 82 131 162 45 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
353 
disease_progression 
H-positive risk:  680 716 81 1105 391 89 1092 442 158 68 132 46 
H-negative risk:  716 680 1092 1105 442 391 89 81 132 158 46 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
354 
disease_progression 
H-positive risk:  676 716 82 1106 394 91 1092 442 158 64 133 46 
H-negative risk:  716 676 1092 1106 442 394 91 82 133 158 46 64 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
355 
disease_progression 
H-positive risk:  684 711 84 1096 400 90 1086 447 161 63 135 43 
H-negative risk:  711 684 1086 1096 447 400 90 84 135 161 43 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
356 
disease_progression 
H-positive risk:  682 712 85 1100 409 90 1076 445 161 63 135 42 
H-negative risk:  712 682 1076 1100 445 409 90 85 135 161 42 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
357 
disease_progression 
H-positive risk:  683 720 85 1106 406 88 1077 438 154 67 132 44 
H-negative risk:  720 683 1077 1106 438 406 88 85 132 154 44 67 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
358 
disease_progression 
H-positive risk:  680 724 91 1109 408 87 1073 434 152 69 129 44 
H-negative risk:  724 680 1073 1109 434 408 87 91 129 152 44 69 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 61 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
359 
disease_progression 
H-positive risk:  681 724 88 1112 409 85 1066 430 154 71 134 46 
H-negative risk:  724 681 1066 1112 430 409 85 88 134 154 46 71 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 62 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
360 
disease_progression 
H-positive risk:  686 722 88 1117 409 84 1057 432 154 70 137 44 
H-negative risk:  722 686 1057 1117 432 409 84 88 137 154 44 70 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 62 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
Time difference of 18.22614 mins
This is task 4
date
